TANDEM DIABETES CARE INC 8-K

What Happened Tandem Diabetes Care, Inc. announced its quarterly financial results by filing a Form 8-K on May 7, 2026. The filing (Item 2.02) furnishes a press release reporting the company’s results for the quarter ended March 31, 2026; that press release is included as Exhibit 99.1 and is incorporated by reference in the 8-K. The report was signed by Shannon M. Hansen, Executive Vice President, Chief Legal, Privacy & Compliance Officer and Secretary.

Key Details

• Filing date: May 7, 2026; quarter covered: quarter ended March 31, 2026.
• Item reported: 2.02 — Results of Operations and Financial Condition (press release furnished as Exhibit 99.1).
• Exhibit included: 99.1 — press release dated May 7, 2026.
• Form signed by Shannon M. Hansen (EVP, Chief Legal, Privacy & Compliance Officer and Secretary).

Why It Matters This 8-K signals that Tandem has publicly released its latest quarterly earnings and related financial information — the primary source investors should consult for updated revenue, profitability, guidance, and operational metrics. Because the 8-K only furnishes the press release, investors should read Exhibit 99.1 (the company’s press release) for the specific numbers and any management commentary that could affect the stock or near-term expectations.